Loading...
Market
Lawsuit filed against pharmaceutical companies over puberty blockers by mid-2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Legal filings or reports from major news outlets
Story
Study Links Puberty Blockers to 26.5x Higher Testicular Cancer Risk
Nov 24, 2024, 01:49 AM
New evidence suggests that long-term treatment with puberty blockers and cross-sex hormones may significantly increase the risk of testicular cancer. A study involving 458 men found that they are 26.5 times more likely to develop testicular cancer after undergoing such treatments. Testicular cancer rates are 26.5x HIGHER in males seeking orchiectomies. This raises serious concerns about the safety and ethical implications of using these treatments in young individuals.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Upheld • 25%
Overturned • 25%
Modified • 25%
Other • 25%
Allowed with parental consent • 25%
Allowed without parental consent • 25%
Not allowed • 25%
Other • 25%
Support the ruling • 25%
Oppose the ruling • 25%
Neutral stance • 25%
Other • 25%
Ban upheld • 25%
Ban overturned • 25%
Ban modified • 25%
No decision • 25%